Sirolimus Cuts Skin Cancer Risk in Transplant Patients
03:46 EDT 27 Jul 2012 | Medscape
A switch to sirolimus appears to reduce the risk for new skin cancers in kidney transplant patients. Medscape Medical News
Original Article: Sirolimus Cuts Skin Cancer Risk in Transplant Patients
More From BioPortfolio on "Sirolimus Cuts Skin Cancer Risk in Transplant Patients"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
